Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-Analysis
出版年份 2011 全文链接
标题
Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-Analysis
作者
关键词
-
出版物
SCHIZOPHRENIA BULLETIN
Volume 39, Issue 2, Pages 306-318
出版商
Oxford University Press (OUP)
发表日期
2011-12-30
DOI
10.1093/schbul/sbr148
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Metabolic syndrome in people with schizophrenia: a review
- (2015) MARC DE HERT et al. World Psychiatry
- Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
- (2015) MARC DE HERT et al. World Psychiatry
- Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
- (2015) MARC DE HERT et al. World Psychiatry
- A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)
- (2011) T. Scott Stroup et al. AMERICAN JOURNAL OF PSYCHIATRY
- Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation
- (2011) M. De Hert et al. BRITISH JOURNAL OF PSYCHIATRY
- Association of the metabolic syndrome with physical activity performance in patients with schizophrenia
- (2011) D. Vancampfort et al. DIABETES & METABOLISM
- Endogenic and Iatrogenic Diabetes Mellitus in Drug-naïve Schizophrenia: The Role of Olanzapine and its Place in the Psychopharmacological Treatment Algorithm
- (2011) Dan Cohen et al. NEUROPSYCHOPHARMACOLOGY
- MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study
- (2010) Ruud van Winkel et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- The Metabolic Syndrome and Cardiovascular Risk
- (2010) Salvatore Mottillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients
- (2010) Jimmi Nielsen et al. NEUROPSYCHOPHARMACOLOGY
- Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia
- (2010) Davy Vancampfort et al. PSYCHIATRY RESEARCH
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA RESEARCH
- Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort
- (2010) Julio Bobes et al. SCHIZOPHRENIA RESEARCH
- MTHFR and risk of metabolic syndrome in patients with schizophrenia
- (2010) Ruud van Winkel et al. SCHIZOPHRENIA RESEARCH
- Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration
- (2009) Lizheng Shi et al. BMC Psychiatry
- Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
- (2009) Emilio Fernandez-Egea et al. BRITISH JOURNAL OF PSYCHIATRY
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic Disorders
- (2009) Mario Álvarez-Jiménez et al. CNS DRUGS
- Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
- (2009) M. De Hert et al. EUROPEAN PSYCHIATRY
- Comorbid Somatic Illnesses in Patients With Severe Mental Disorders
- (2009) W. Wolfgang Fleishhacker et al. JOURNAL OF CLINICAL PSYCHIATRY
- Metabolic Risk Factors in Drug-Naive Patients With First-Episode Psychosis
- (2009) Swapna K. Verma et al. JOURNAL OF CLINICAL PSYCHIATRY
- Weight gain in antipsychotic-naive patients: a review and meta-analysis
- (2009) I. Tarricone et al. PSYCHOLOGICAL MEDICINE
- Assessing metabolic syndrome: Waist circumference versus BMI
- (2009) Bonnie L. Szarek et al. SCHIZOPHRENIA RESEARCH
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- The metabolic syndrome and schizophrenia
- (2008) J. M. Meyer et al. ACTA PSYCHIATRICA SCANDINAVICA
- Insulin sensitivity, adjusted β-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: A nine-month prospective study
- (2008) P. Oriot et al. DIABETES & METABOLISM
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
- Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review
- (2008) Marc De Hert et al. SCHIZOPHRENIA RESEARCH
- Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population
- (2008) Rocio Perez-Iglesias et al. SCHIZOPHRENIA RESEARCH
- Mortality in schizophrenia and schizoaffective disorder: An Olmsted County, Minnesota cohort: 1950–2005
- (2007) Rebecca M. Capasso et al. SCHIZOPHRENIA RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started